During the past decade, Istituto Nazionale Tumori Regina Elena conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 17 clinical trials were completed, i.e. on average, 35.4% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 12 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Istituto Nazionale Tumori Regina Elena" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Janssen Research & Development, LLC" with 9 trials sponsored, "Celgene" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 4 trials sponsored and "Incyte Corporation" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Nazionale Tumori Regina Elena" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Alleanza Contro il Cancro" with 1 trials as a collaborator, "BAYER S.p.A. - Italia" with 1 trials as a collaborator, "Bocconi University" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Istituto Nazionale Tumori Regina Elena" are "Carcinoma, Non-Small-Cell Lung" (6 trials), "Melanoma" (6 trials), "Neoplasms" (4 trials), "Breast Cancer" (3 trials) and "Carcinoma, Bronchogenic" (3 trials). Many other conditions were trialed in "Istituto Nazionale Tumori Regina Elena" in a lesser frequency.

Most popular intervention types in "Istituto Nazionale Tumori Regina Elena" are "Drug" (51 trials), "Biological" (5 trials), "Radiation" (4 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (7 trials), "Carboplatin" (6 trials), "Docetaxel" (5 trials), "Placebo" (5 trials) and "Cisplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Istituto Nazionale Tumori Regina Elena" are 54 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Istituto Nazionale Tumori Regina Elena". undefined are not yet recruiting, 24 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Istituto Nazionale Tumori Regina Elena, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Istituto Nazionale Tumori Regina Elena, 6 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".